EGFR vIII and RRAD expression in glioblastoma tissue is associated with poor prognosis and correlated with activation of the EGFR/STAT3 pathway along with resistance of cancer cells to cytotoxic drugs11,12 . This evidence concerns the gene EGFR and glioblastoma.